MedTrace Logo

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

NCT02014805 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2020-07-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether postoperative conformal radiotherapy are effective in the treatment of Masaoka stage II-III B type thymoma.

Conditions

  • Thymoma

Interventions

RADIATION

radiotherapy

postoperative conformal radiotherapy for Masaoka stage II-III B type thymoma

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV

  • 309th Hospital of Chinese People's Liberation Army

    collaborator OTHER

  • Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Qinfu Feng, M.D. · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2021-07-31
Completion
2022-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014805 on ClinicalTrials.gov